Planned website maintenance is taking place from 11:00 pm AEDT on Friday 30 October to 6:00 am AEDT on Saturday 31 October 2026. Some pages may be temporarily unavailable. If issues continue outside this time, please contact us.
Sponsor content
359 result(s) found, displaying 111 to 120
-
Prescription medicine registrationActive ingredients: Pneumococcal purified capsular polysaccharides.
-
Prescription medicine registrationActive ingredients: belzutifan.
-
Prescription medicine registrationActive ingredients: pembrolizumab.
-
Cancellation by sponsorRequested by Merck Sharp & Dohme (Australia) Pty Ltd
-
Australian Public Assessment Report (AusPAR)AusPAR for Vaxneuvance (pneumococcal 15-valent conjugate vaccine (CRM197 protein), adsorbed) for the prevention of pneumococcal disease.
-
Designation or determinationProvisional determination
-
Prescription medicine registrationActive ingredients: pembrolizumab.
-
Prescription medicine registrationActive ingredients: pembrolizumab.
-
Prescription medicine registrationActive ingredients: pembrolizumab.
-
Cancellation by sponsorRequested by Merck Sharp & Dohme (Australia) Pty Ltd